Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 76

Coral corrals corporates for $45m Japan fund

The 500 Startups Japan team have spun off as Coral Capital and launched a $45m fund backed by Mitsubishi Estate, J-Power, Mizuho Bank and Shinsei Bank.

Mar 7, 2019

Vilmorin & Cie passes into PSL fund

Vilmorin & Cie has joined fellow corporates including BNP Paribas, Naval Group, KPN, Famille C and Mgen as an investor in PSL Innovation Fund, which is targeting an $87.5m close.

Mar 6, 2019

Ravina rises at Engie EPS

Engie New Ventures alumnus Giovanni Ravina, became chief innovation officer for another Engie subsidiary, Engie EPS, in January this year.

Mar 5, 2019

BFG meets corporates for giant $100m fund

The venture capital firm has sourced commitments from investors including Arlon Group and Rabobank for a $100m food and beverage-focused fund known as BFG Fund II.

Mar 4, 2019

Folau joins LMI Ventures

Ian Folau, a co-founder and former CEO of GitLinks, has been hired by the recently launched LMI Ventures as a managing director.

Feb 26, 2019

Mubadala mobilises SoftBank in $400m fund

SoftBank has reportedly invested $200m in a Europe-focused venture capital fund formed by Mubadala, which had committed $15bn to its Vision Fund two years ago.

Feb 19, 2019

Straub gets the rub at Bioventure

Siemens Technology Accelerator venture director Nico Straub has taken a partner position at Bioventure Consulting after nearly six years at the unit.

Feb 14, 2019

MML seeks corporate commitments for second fund

The Irish private equity investor is reportedly approaching AIG, Goldpoint and Cigna, all of which backed the firm's debut vehicle in 2013, for commitments to its Fund II.

Feb 14, 2019

Armilar accepts Semapa and KNP for fifth fund

The corporate venturing units of Semapa and KPN have contributed to Armilar's TechTransfer Fund, which has raised almost $51m on its way to a target of about $68m.

Feb 13, 2019

HiberCell absorbs series A funding

The metastatic cancer drug developer has secured $60.8m from investors including Celgene and the WuXi AppTec-backed 6 Dimensions Capital.

Feb 11, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here